TrialInternational journal of cardiology2013

Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis.

Myeong Ho Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.